Overview

The Effect of Intranasal Insulin on Motor and Non-motor Symptoms in Parkinson's Disease Patients

Status:
Recruiting
Trial end date:
2022-07-01
Target enrollment:
Participant gender:
Summary
This study will evaluate the effect of intranasal insulin on motor and non-motor symptoms of patients with Parkinson's disease over a 12-week period.
Phase:
Phase 2
Details
Lead Sponsor:
dr.dargahi
Treatments:
Insulin
Insulin, Globin Zinc